Pharmacoeconomic Analysis of the Use of a Fixed Dose Combination of Metformin and Glibenclamide in the Therapy of Diabetes Mellitus Type 2

Pharmacoeconomics: theory and practice
doi 10.30809/phe.3.2016.1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Moscow Pharmaceutical Society

Related search

Pioglitazone and Metformin Fixed-Dose Combination in Type 2 Diabetes Mellitus: An Evidence-Based Review of Its Place in Therapy

Core Evidence
MedicineReviewsReferencesPharmacology
2007English

Empagliflozin and Metformin Combination Therapy in Type 2 Diabetes Mellitus

International Journal of Basic and Clinical Pharmacology
2015English

Effect of Metformin and Rosiglitazone Combination Therapy in Patients With Type 2 Diabetes Mellitus

JAMA - Journal of the American Medical Association
Medicine
2000English

Drowsiness Associated With a Generic Fixed‐dose Glibenclamide/Metformin Combination Tablet

Journal of Pharmacy Practice and Research
PharmacologyPharmacy
2019English

A Retrospective Comparison Study Between the Effectiveness and Safety of Fixed Dose Combination of Vildagliptin Versus Sitagliptin With Metformin in Type 2 Diabetes Mellitus Patients

Indian Journal of Pharmacy Practice
2018English

Formulation and Optimization of Monolithic Fixed-Dose Combination of Metformin HCl and Glibenclamide Orodispersible Tablets

Advances in Pharmacological and Pharmaceutical Sciences
2020English

Comparison of Antioxidative Effect of Metformin and Combination of Metformin-Sulfonylurea in Type 2 Diabetes Mellitus Patients

Journal of Young Pharmacists
ToxicologyPharmaceuticsPharmacology
2017English

Pharmacoeconomic Analysis of Type 2 Diabetes Mellitus and Its Microvascular Complications

International Journal of Research in Hospital and Clinical Pharmacy
2018English

A Clinical Study on Adverse Drug Reactions of Combination Therapy of Dapagliflozin and Metformin in the Treatment of Type 2 Diabetes Mellitus

Asian Journal of Pharmaceutical and Clinical Research
PharmacologyPharmaceutical Science
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy